(18.47) There is evidence that cytotoxic T lymphocytes ( T cells) participate in controlling tumor growth and that they can be harnessed to use the body's immune system to treat cancer. One study investi-gated the use of a T cell- engaging antibody, blinatumomab, to recruit T cells to control tumor growth. The data below are T cell counts ( 1000 per microliter) at baseline ( beginning of the study) and after 20 days on blinatumomab for 6 subjects in the study. The difference ( after 20 days minus baseline) is the response variable.

Baseline 0.04 0.02 0 0.02 0.38 0.34
After

Question

(18.47) There is evidence that cytotoxic T lymphocytes ( T cells) participate in controlling tumor growth and that they can be harnessed to use the body's immune system to treat cancer. One study investi-gated the use of a T cell- engaging antibody, blinatumomab, to recruit T cells to control tumor growth. The data below are T cell counts ( 1000 per microliter) at baseline ( beginning of the study) and after 20 days on blinatumomab for 6 subjects in the study. The difference ( after 20 days minus baseline) is the response variable.

Baseline 	        0.04  	0.02  	0  	0.02  	0.38  	0.34 
After